← Leaderboards
Sandro Belvedere
Forkhead Biotherapeutics, Inc.
$584,112
Attributed
$584,112
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$584,112 · 1
By mechanism
R44$584,112 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Adme Study”
- Timothy M Willson · University Of Cape Town$12,760,250
- Anna Upton · Global Alliance For Tb Drug Development$10,496,979
- Christian Arthur Heidbreder · Indivior, Inc.$8,483,680
- John Damon Chodera · Sloan-Kettering Inst Can Research$8,477,219
- James Jeffrey Sahn · 4e Therapeutics Inc.$7,126,294
- Deborah Bunin · Sri International$6,795,541
Research focus
Adme StudyAdverse EffectsAnimal EfficacyAnimalsAreaArtificial PancreasAutoimmuneAwardBaseBeta CellBiological AvailabilityBiological Response Modifier TherapyBlood GlucoseBlood Glucose RegulationBlood VesselsB-LymphocytesCaringCell PhysiologyCellsCell TherapyCessation Of LifeChemistryChronicAblation